2023-09-01 2024-08-31 false Capium Accounts Production 1.1 07734528 2023-09-01 2024-08-31 07734528 bus:FullAccounts 2023-09-01 2024-08-31 07734528 bus:FRS102 2023-09-01 2024-08-31 07734528 bus:AuditExemptWithAccountantsReport 2023-09-01 2024-08-31 07734528 bus:SmallCompaniesRegimeForAccounts 2023-09-01 2024-08-31 07734528 bus:PrivateLimitedCompanyLtd 2023-09-01 2024-08-31 07734528 2023-09-01 2024-08-31 07734528 2024-08-31 07734528 bus:RegisteredOffice 2023-09-01 2024-08-31 07734528 core:WithinOneYear 2024-08-31 07734528 core:AfterOneYear 2024-08-31 07734528 1 2023-09-01 2024-08-31 07734528 bus:Director1 2023-09-01 2024-08-31 07734528 bus:Director1 2024-08-31 07734528 bus:Director1 2022-09-01 2023-08-31 07734528 bus:Director2 2023-09-01 2024-08-31 07734528 bus:Director2 2024-08-31 07734528 bus:Director2 2022-09-01 2023-08-31 07734528 2022-09-01 07734528 bus:LeadAgentIfApplicable 2023-09-01 2024-08-31 07734528 2022-09-01 2023-08-31 07734528 2023-08-31 07734528 core:WithinOneYear 2023-08-31 07734528 core:AfterOneYear 2023-08-31 07734528 bus:EntityAccountantsOrAuditors 2022-09-01 2023-08-31 07734528 bus:OrdinaryShareClass1 2023-09-01 2024-08-31 07734528 bus:OrdinaryShareClass1 2024-08-31 07734528 bus:OrdinaryShareClass1 2022-09-01 2023-08-31 07734528 bus:OrdinaryShareClass1 2023-08-31 07734528 core:MotorCars 2023-09-01 2024-08-31 07734528 core:MotorCars 2024-08-31 07734528 core:MotorCars 2023-08-31 07734528 core:FurnitureFittings 2023-09-01 2024-08-31 07734528 core:FurnitureFittings 2024-08-31 07734528 core:FurnitureFittings 2023-08-31 07734528 core:ComputerEquipment 2023-09-01 2024-08-31 07734528 core:ComputerEquipment 2024-08-31 07734528 core:ComputerEquipment 2023-08-31 07734528 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-08-31 07734528 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2023-08-31 07734528 core:CostValuation core:Non-currentFinancialInstruments 2024-08-31 07734528 core:CostValuation core:Non-currentFinancialInstruments 2023-08-31 07734528 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2024-08-31 07734528 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2024-08-31 07734528 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2024-08-31 07734528 core:Non-currentFinancialInstruments 2024-08-31 07734528 core:Non-currentFinancialInstruments 2023-08-31 07734528 core:ShareCapital 2024-08-31 07734528 core:ShareCapital 2023-08-31 07734528 core:RetainedEarningsAccumulatedLosses 2024-08-31 07734528 core:RetainedEarningsAccumulatedLosses 2023-08-31 07734528 dpl:Item1 2023-09-01 07734528 dpl:Item1 2024-08-31 07734528 dpl:Item1 2022-09-01 07734528 dpl:Item1 2023-08-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 07734528
England and Wales

 

 

 

GOLDER MEDICAL SERVICES LTD


Unaudited Financial Statements
 


Period of accounts

Start date: 01 September 2023

End date: 31 August 2024
Directors Dr. M. S. Golder
Susan Golder
Registered Number 07734528
Registered Office Unit 15 City Business Centre
Lower Road
London
SE16 2XB
Accountants Cocke Vellacott & Hill
Chartered Accountants
Unit 15 City Business Centre
Lower Road
London
SE16 2XB
Bankers HSBC plc
28 Borough High Street
Southwark
London
SE1 1YB

1
Director's report and financial statements
The directors present report and unaudited accounts for the year ended 31 August 2024.
Principal activities
The principal activity of the company during the financial year was that of the provision of general medical services.
Directors
The directors who served the company throughout the year were as follows:
Dr. M. S. Golder
Susan Golder
Statement of directors' responsibilities
The directors are responsible for preparing the directors' report and the financial statements in accordance with applicable law and regulations and in accordance with United Kingdom Generally Accepted Accounting Practice.
Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (Financial Reporting Standard 102). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and the profit or loss of the company for that period.
In preparing these financial statements, the directors are required to :
  • select suitable accounting policies and then apply them consistently
  • make judgements and accounting estimates that are reasonable and prudent
  • state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements and
  • prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.
The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company’s transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
The directors are responsible for the maintenance and integrity of the corporate and financial information included on the company's website. Legislation in the United Kingdom, governing the preparation and dissemination of financial statements, may differ from legislation in other jurisdictions
Small company regime
This report has been prepared in accordance with the special provisions relating to companies subject to the small companies regime with Part 15 of the Companies Act 2006.
Audit exemption
Golder Medical Services Limited has taken advantage of the exemption under Section 477 of the Companies Act 2006 and these financial statements are therefore unaudited.

This report was approved by the board and signed on its behalf by:


----------------------------------
Dr. M. S. Golder
Director

Date approved: 12 May 2025
2
 
 
Notes
 
2024
£
  2023
£
Fixed assets      
Tangible fixed assets 3 791    1,820 
791    1,820 
Current assets      
Debtors: amounts falling due within one year 4 5,000    3,000 
Cash at bank and in hand 1,224    5,943 
6,224    8,943 
Creditors: amount falling due within one year 5 (1,579)   (1,813)
Net current assets 4,645    7,130 
 
Total assets less current liabilities 5,436    8,950 
Provisions for liabilities 6 (340)   (536)
Net assets 5,096    8,414 
 

Capital and reserves
     
Called up share capital 7 1    1 
Profit and loss account 5,095    8,413 
Shareholders' funds 5,096    8,414 
 


For the year ended 31 August 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.
The financial statements were approved by the board of directors on 12 May 2025 and were signed on its behalf by:


-------------------------------
Dr. M. S. Golder
Director
3
General Information
GOLDER MEDICAL SERVICES LTD is a private company, limited by shares, domiciled in England and Wales, registration number 07734528. The address of its registered office is Unit 15 City Business Centre, London, SE16 2XB.

The presentation currency is £ sterling which is the company's functional currency.

The current year financial statements are for the year to 31 August 2024. The comparative figures are for the year to 31 August 2023. 
1.

Accounting policies

Basis of accounting
The financial statements are prepared under the historical cost convention and in accordance with the Financial Reporting Standard 102 Section 1A, 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (FRS 102) and the Companies Act 2006.
Turnover
Turnover is measured at the fair value of the consideration received or receivable and represents the amount receivable for goods supplied or services rendered by the company, net of Value Added Tax and trade discounts.
Taxation
Taxation represents the sum of tax currently payable and deferred tax.
Current tax is recognised for the amount of income tax payable in respect of the taxable profit for the current or past years and it is calculated using tax rates that have been enacted or substantially enacted by the end of the reporting period.

Deferred tax is recognised on all timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profits. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered.
Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period
Deferred taxation
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the reporting date.
Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.
Current and deferred tax assets and liabilities are not discounted.
Dividends
Proposed dividends are only included as liabilities in the statement of financial position when their payment has been approved by the shareholders prior to the statement of financial position date.



Tangible fixed assets
Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
Fixtures and Fittings 25% Straight Line
Computer Equipment 33% Straight Line
Provisions
Provisions are recognised when the company has a present obligation as a result of a past event which it is more probable than not will result in an outflow of economic benefits that can be reasonably estimated.
2.

Average Number of Employees

The company was administered by its director.
Average number of employees during the year was 0 (2023 : 0).
3.

Tangible fixed assets

Cost or valuation Motor Vehicles   Fixtures and Fittings   Computer Equipment   Total
  £   £   £   £
At 01 September 2023 550    42,124    9,485    52,159 
Additions      
Disposals      
At 31 August 2024 550    42,124    9,485    52,159 
Depreciation
At 01 September 2023 185    42,124    8,030    50,339 
Charge for year 91      938    1,029 
On disposals      
At 31 August 2024 276    42,124    8,968    51,368 
Net book values
Closing balance as at 31 August 2024 274      517    791 
Opening balance as at 01 September 2023 365      1,455    1,820 


4.

Debtors: amounts falling due within one year

2024
£
  2023
£
Prepayments & Accrued Income 5,000    3,000 
5,000    3,000 

5.

Creditors: amount falling due within one year

2024
£
  2023
£
Corporation Tax   395 
Accrued Expenses 1,413    1,362 
Directors' Current Accounts 166    56 
1,579    1,813 

6.

Provisions for liabilities

2024
£
  2023
£
Deferred Tax 340    536 
340    536 

7.

Share Capital

Authorised
1 Class A share of £1.00 each
Allotted, called up and fully paid
2024
£
  2023
£
1 Class A share of £1.00 each  
 

4